Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 11—November 2006
Dispatch

Human Parainfluenza Type 4 Infections, Canada

Marie-Louise Vachon*†, Natasha Dionne*†, Éric Leblanc*†, Danielle Moisan‡, Michel G. Bergeron*†, and Guy Boivin*†Comments to Author 
Author affiliations: *Research Center in Infectious Diseases of the Centre Hospitalier Universitaire de Québec, Quebec City, Quebec, Canada; †Laval University, Quebec City, Quebec, Canada; ‡Centre Hospitalier Régional du Grand-Portage, Rivière-du-Loup, Quebec, Canada

Main Article

Table 2

Clinical data of 9 patients with HPIV-4 infections in Quebec City, Canada*

Patient Sample type (date of collection) Age/sex Underlying Illness Symptoms and signs Hospital-ization (d) Final diagnosis
1 NPA (2004 Dec 5) 1.5 mo/M – Cough, apnea, fever, low O2 sat. Yes, ICU (3) Bronchiolitis
2 NPA (2004 Oct 20) 2.5 mo/M Premature (32 wk), POF, PPS Cough, apnea, low O2 sat. Yes (14) Bronchiolitis
3 NPA (2004 Nov 2) 3 mo/M – Cough, apnea, BOM Yes (2) URTI and BOM
4 NPA (2005 Jan 4) 5 mo/M Premature (33 wk) Cough, fever No URTI
5 NPA (2005 Jan 19) 6 mo/F Premature (26 wk), PD Rhinorrhea, wheezing No Bronchiolitis
6 NPA (2004 Nov 18) 2.7 y/F Asthma Rhinorrhea, cough, wheezing No Sinusitis and bronchospasm
7 TS (2005 Mar 8) 25 y/M – Fever, right tonsil ulcerative lesions No Viral pharyngitis
8 NPA (2005 Jan 25) 84 y/F CHD, COPD Dyspnea, low O2 sat., cyanosis Yes (14) PE, MI, and persisting bronchospasm
9 NPS (2005 Jan 21) 90 y/F AF, dementia Fever, muscle aches No Flulike syndrome

*HPIV-4, human parainfluenza virus type 4; NPA, nasopharyngeal aspirate; O2 sat., oxygen saturation; ICU, intensive care unit; POF, permeable oval foramen; PPS, peripheral pulmonary stenosis; BOM, bilateral otitis media; URTI, upper respiratory tract infection; PD, pulmonary dysplasia; TS, throat swab; CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease; PE, pulmonary edema; MI, myocardial infarction; NPS, nasopharyngeal swab; AF, atrial fibrillation.

*HPIV-4, human parainfluenza virus type 4; NPA, nasopharyngeal aspirate; O2 sat., oxygen saturation; ICU, intensive care unit; POF, permeable oval foramen; PPS, peripheral pulmonary stenosis; BOM, bilateral otitis media; URTI, upper respiratory tract infection; PD, pulmonary dysplasia; TS, throat swab; CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease; PE, pulmonary edema; MI, myocardial infarction; NPS, nasopharyngeal swab; AF, atrial fibrillation.

Main Article

Page created: October 14, 2011
Page updated: October 14, 2011
Page reviewed: October 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external